Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of antibodies to hepatitis C virus glycoproteins 1 and 2 (anti-E1E2) with HCV disease.

Journal of viral hepatitis - 1 May 2008

Hamed M R B, Tarr A W, McClure C P, Ball J K, Hickling T P, Irving W L

Abstract excerpt

Hepatitis C virus (HCV) causes acute and chronic liver diseases in humans. Its two envelope glycoproteins, E1 and E2, provide a target for host immune recognition. HCV genotypes are classified into six genetic groups. To study the role of anti-HCV E1 and E2 (anti-E1E2) in HCV disease, the correlation between antibody level and viral load, genotype, disease severity and response to treatment was investigated. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Viral
Share to Antiviral Agents
Share to Enzyme-Linked Immunosorbent Assay

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Liver Cirrhosis

Share to Statistics as Topic

Share to Viral Envelope Proteins

Share to Viral Load

Source

Identifiers

PMID: 18221305
DOI: 10.1111/j.1365-2893.2007.00947.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of antibodies to hepatitis C virus glycoproteins 1 and 2 (anti-E1E2) with HCV disease.PMID 18221305Read ↗

Combination of neutralizing monoclonal antibodies against Hepatitis C virus E2 protein effectively blocks virus infection.Semantic proximity Read ↗

Characterisation of the differences between hepatitis C virus genotype 3 and 1 glycoproteins.Semantic proximity Read ↗

Conformational epitopes detected by cross-reactive antibodies to envelope 2 glycoprotein of the hepatitis C virus.Semantic proximity Read ↗

Cross-reactivity and clinical impact of the antibody response to hepatitis C virus second envelope glycoprotein (E2).Semantic proximity Read ↗

Isolation and Characterization of Broadly Neutralizing Human Monoclonal Antibodies to the E1 Glycoprotein of Hepatitis C VirusSemantic proximity Read ↗

Circulating viral core and E1 antigen levels as supplemental markers for HCV chronic hepatitis.Semantic proximity Read ↗

Hepatitis C virus genotypes, reactivity to recombinant immunoblot assay 2 antigens and liver disease.Semantic proximity Read ↗

Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity.Semantic proximity Read ↗

Determination of the human antibody response to the neutralization epitopes encompassing amino acids 313-327 and 432-443 of hepatitis C virus E1E2 glycoproteins.Semantic proximity Read ↗

The immunoreactivity profile of different HCV genotypes on immunoblot assay and its implications in the development of diagnostic assays.Semantic proximity Read ↗

The relationship between virological characteristics of hepatitis C virus (HCV) and reactivity to the regional specific proteins of HCV.Semantic proximity Read ↗

Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.